Fortem Financial Group, LLC Grifols Sa Transaction History

Fortem Financial Group, LLC

  • $226 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$19.85 - $22.76 $227,997 - $261,421
-11,486 Closed
0 $0
Q2 2019

Aug 09, 2019
SELL
$17.59 - $21.1 $14,810 - $17,766
-842 Reduced 6.83%
11,486 $242,000
Q1 2019

May 13, 2019
SELL
$18.01 - $20.11 $1,710 - $1,910
-95 Reduced 0.76%
12,328 $248,000
Q4 2018

Feb 14, 2019
BUY
$17.44 - $21.53 $216,657 - $267,467
12,423 New
12,423 $228,000

Others Institutions Holding GRFS

# of Institutions
147
Shares Held
151M
Call Options Held
2.38M
Put Options Held
662K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email